Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6
- PMID: 9261944
- DOI: 10.1016/s0264-410x(96)00296-4
Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6
Abstract
The outer membrane lipoprotein, P6 of Haemophilus influenzae was studied to determine the importance of the native palmitoyl moiety on its physicochemical and immunological properties. A recombinant P6 (rP6) molecule devoid of lipidation signal sequence was expressed in Escherichia coli and its properties were compared to those of the palmitylated protein purified from H. influenzae. The isoelectric point of rP6 was more acidic than that of the native protein and also exhibited less secondary structure than P6 as judged by circular dichroism. However, both forms of P6 induced identical P6-specific antibody titers in guinea pigs when Freund's adjuvant was used. These antisera reacted with a panel of overlapping P6 peptides in a comparable manner and in addition, rabbit antisera raised against the P6 peptides reacted equally well with P6 and rP6. Furthermore, all human convalescent sera tested exhibited similar anti-P6 and anti-rP6 antibody titers. However, rP6 was less immunogenic than P6 when administered either without adjuvant or in alum and when tested in competitive inhibition studies with anti-P6 antibodies, was a less effective inhibitor than native P6, suggesting a diminution in some of the antigenic activity of rP6. In spite of these differences, rP6 was capable of eliciting a protective antibody response against live H. influenzae type b challenge in a modified infant rat model of bacteremia. These findings demonstrate that the non-fatty acylated rP6 could possibily be substituted for native P6 in a vaccine against H. influenzae.
Similar articles
-
A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.Vaccine. 2005 Jan 26;23(10):1294-300. doi: 10.1016/j.vaccine.2004.08.042. Vaccine. 2005. PMID: 15652672
-
Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.J Infect Dis. 2004 Apr 1;189(7):1304-12. doi: 10.1086/382508. Epub 2004 Mar 17. J Infect Dis. 2004. PMID: 15031801
-
[Mouse macrophage-derived chemokine as an adjuvant enhances the protective effect of P6 protein vaccine of nontypeable Haemophilus influenzae].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Sep;30(9):913-6. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014. PMID: 25200152 Chinese.
-
Studies on P6, an important outer-membrane protein antigen of Haemophilus influenzae.Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S331-6. doi: 10.1093/cid/10.supplement_2.s331. Rev Infect Dis. 1988. PMID: 3055201 Review.
-
Developing a nontypeable Haemophilus influenzae (NTHi) vaccine.Vaccine. 2000 Dec 8;19 Suppl 1:S108-15. doi: 10.1016/s0264-410x(00)00288-7. Vaccine. 2000. PMID: 11163473 Review.
Cited by
-
Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilus influenzae.Infect Immun. 2006 Sep;74(9):5169-76. doi: 10.1128/IAI.00692-06. Infect Immun. 2006. PMID: 16926409 Free PMC article.
-
Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung.Infect Immun. 1999 May;67(5):2138-44. doi: 10.1128/IAI.67.5.2138-2144.1999. Infect Immun. 1999. PMID: 10225866 Free PMC article.
-
Nontypeable Haemophilus influenzae: pathogenesis and prevention.Microbiol Mol Biol Rev. 1998 Jun;62(2):294-308. doi: 10.1128/MMBR.62.2.294-308.1998. Microbiol Mol Biol Rev. 1998. PMID: 9618443 Free PMC article.
-
Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines.Infect Immun. 2005 May;73(5):2728-35. doi: 10.1128/IAI.73.5.2728-2735.2005. Infect Immun. 2005. PMID: 15845475 Free PMC article.
-
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines.Infect Immun. 1997 Dec;65(12):4918-25. doi: 10.1128/iai.65.12.4918-4925.1997. Infect Immun. 1997. PMID: 9393776 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials